Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Revenue (2020 - 2025)

Historic Revenue for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $18.5 million.

  • Burning Rock Biotech's Revenue rose 85.65% to $18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.8 million, marking a year-over-year increase of 475.4%. This contributed to the annual value of $70.7 million for FY2024, which is 664.37% down from last year.
  • Burning Rock Biotech's Revenue amounted to $18.5 million in Q3 2025, which was up 85.65% from $20.7 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Revenue ranged from a high of $23.1 million in Q4 2021 and a low of $16.3 million during Q1 2021
  • Over the past 5 years, Burning Rock Biotech's median Revenue value was $19.5 million (recorded in 2022), while the average stood at $19.3 million.
  • As far as peak fluctuations go, Burning Rock Biotech's Revenue surged by 3136.91% in 2022, and later tumbled by 1956.48% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Revenue (Quarter) stood at $23.1 million in 2021, then dropped by 10.81% to $20.6 million in 2022, then fell by 17.3% to $17.1 million in 2023, then rose by 1.24% to $17.3 million in 2024, then grew by 7.08% to $18.5 million in 2025.
  • Its Revenue stands at $18.5 million for Q3 2025, versus $20.7 million for Q2 2025 and $18.3 million for Q1 2025.